The effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on pain, quality of life and physical function in patients with meniscopathy: a randomized, double-blind, placebo-controlled study.

Genç, Ahmet Serhat et al.·BMC musculoskeletal disorders·2025·
RPEP-110832025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
The effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on pain, quality of life and physical function in patients with meniscopathy: a randomized, double-blind, placebo-controlled study.
Published In:
BMC musculoskeletal disorders, 26(1), 17 (2025)
Database ID:
RPEP-11083

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11083·https://rethinkpeptides.com/research/RPEP-11083

APA

Genç, Ahmet Serhat; Yılmaz, Ali Kerim; Anıl, Berna; Korkmaz Salkılıç, Esra; Akdemir, Enes; Güzel, Berna; Mor, Ahmet; Yarar, Hacı Ahmet; Güzel, Nizamettin; Kehribar, Lokman. (2025). The effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on pain, quality of life and physical function in patients with meniscopathy: a randomized, double-blind, placebo-controlled study.. BMC musculoskeletal disorders, 26(1), 17. https://doi.org/10.1186/s12891-024-08244-w

MLA

Genç, Ahmet Serhat, et al. "The effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on pain, quality of life and physical function in patients with meniscopathy: a randomized, double-blind, placebo-controlled study.." BMC musculoskeletal disorders, 2025. https://doi.org/10.1186/s12891-024-08244-w

RethinkPeptides

RethinkPeptides Research Database. "The effect of supplementation with type I and type III colla..." RPEP-11083. Retrieved from https://rethinkpeptides.com/research/genc-2025-the-effect-of-supplementation

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.